Financials

  • Market Capitalization 15.23 M
  • Employee 25
  • Founded 1986
  • CEO Carl Spana
  • Website www.palatin.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BN9PY4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.65
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4549
DYAI
Dyadic International, Inc. - Common Stock
0.42 USD-4.55%-10.64%-12.50%-61.47%15.30 M USD
4551
TCRX
TScan Therapeutics, Inc. - Common Stock
0.24 USD0.00%-17.24%-25.00%-89.04%15.24 M USD
4558
KTTA
Pasithea Therapeutics Corp. - Common Stock
0.45 USD-4.26%-4.26%-13.46%-38.36%15.04 M USD
4565
PASG
Passage Bio, Inc. - Common Stock
4.55 USD+23.31%+8.59%-7.14%-48.53%14.64 M USD

Notizie